Residual blood burning treatment device for drug clinical test

A technology for clinical trials and treatment devices, which is applied in the field of residual blood burning treatment devices for clinical trials of drugs. It can solve problems such as poor sealing of blood collection tubes, leakage of residual blood, and unpleasant smell, so as to improve the efficiency and effect of burning , prevent the growth of bacteria, prolong the effect of residence time

Active Publication Date: 2021-08-10
LUOYANG CENT HOSPITAL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] 1) The blood collection tube is not tightly sealed, resulting in leakage of remaining blood and affecting the environment;
[0006] 2) After being stored for a long time in the warehouse, the remaining blood will deteriorate and the smell will be very unpleasant, especially in summer when the temperature is high;

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Residual blood burning treatment device for drug clinical test
  • Residual blood burning treatment device for drug clinical test
  • Residual blood burning treatment device for drug clinical test

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0037] Such as figure 1 with 2 As shown, a residual blood burning treatment device for drug clinical trials includes a closed cylindrical box 1, and the inside of the cylindrical box 1 is divided into an upper residual blood adsorption chamber 102 and a lower burning treatment chamber. 103, wherein, the residual blood adsorption cavity 102 is filled with the storage material 3 for absorbing residual blood, the top of the residual blood adsorption cavity 102 has a residual blood pouring port 101 into which the residual blood is poured, and the residual blood pouring port 101 has a The opened cover plate has an inclined bottom, and is provided with a discharge port 108 at the lowest point to discharge the storage material to the burning treatment chamber 103. The discharge port 108 has a valve plate controlled by a solenoid valve, and its opening and closing are controlled by a PLC intelligent controller. Closed, a screen 1011 is obliquely arranged below the discharge port 108 ...

Embodiment 2

[0041] This embodiment is an improvement made on the basis of embodiment 1. Its main structure is the same as that of embodiment 1. The improvement is that the storage material 3 is iron sand, porous ceramic particles, montmorillonite particles and Quicklime is formed by mixing in a mass ratio of 2:3:4:1, and the particle diameters of iron sand, porous ceramic particles and montmorillonite particles are all 1-3mm.

Embodiment 3

[0043] This embodiment is another improvement made on the basis of embodiment 1, its main structure is the same as that of embodiment 1, and the improvements are as follows: Figure 7 As shown, the raising and dispersing mechanism 4 includes a rotating cylinder 401 driven by a power mechanism, the axial direction of the rotating cylinder 401 is parallel to the side of the screen 1011, and is equal to the side of the screen 1011; The outer wall of the drum 401 is distributed with at least three metal elastic dials 402 that are as long as the drum 401. The distance between the movement track of the metal elastic dials 402 and the side wall of the screen 1011 is 1 cm. The drum 401 drives the metal elastic dials 402 During clockwise rotation, the particles with large particle size or fast speed in the storage material rolled down along the screen 1011 are lifted up by the metal elastic dial 402, and return to the burning zone 1013 above the screen 1011 to be burned by two The rest...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
Login to view more

Abstract

A residual blood burning treatment device for a drug clinical test is characterized in that the interior of a box body is divided into an upper residual blood adsorption cavity and a lower burning treatment cavity, the residual blood adsorption cavity is filled with a storage material for adsorbing residual blood, the top of the residual blood adsorption cavity is provided with a residual blood pouring port for pouring the residual blood into the residual blood adsorption cavity, and the bottom of the residual blood adsorption cavity is obliquely arranged; and the lowest position of the burning treatment cavity is provided with a discharge port for discharging the storage material to the burning treatment cavity, a screen is obliquely arranged below the discharge port in the burning treatment cavity, a raising and dispersing mechanism is arranged on the lower side of the screen, and a gas burner is arranged below the screen. By arranging the storage material, residual blood is absorbed and stored, after the residual blood is accumulated for a period of time, the storage material for absorbing the residual blood is burnt, organic matter in the residual blood is carbonized and burnt, the screen arranged in the burning treatment cavity is matched with the raising and dispersing mechanism, the storage material for absorbing hardened residual blood can be dispersed, the burning efficiency and effect are improved, and energy is saved.

Description

technical field [0001] The invention relates to the field of clinical trials of medicines, in particular to a burning treatment device for residual blood used in clinical trials of medicines. Background technique [0002] In drug clinical trials, it is often necessary to take blood samples from volunteers after medication for index testing, and after the blood samples are taken, they need to be centrifuged to obtain serum and send it to a third-party testing agency for testing, and the remaining blood samples are used clinically. It is called "residual blood", which generally has no test value and is handled by the clinical trial center itself; [0003] Since the remaining blood is composed of water and organic matter, if it is discharged directly into the sewer without treatment, it will become a "medium" for the growth of bacteria and germs; and the existing treatment method is generally to combine these remaining blood with direct packaging Centralized treatment of medica...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): B01D15/02B01D15/16B01D15/20B01D15/24B01D53/04B01D53/14B01D53/18B01J20/34B08B3/10F23G5/12F23G5/44F23G7/00
CPCB01D15/02B01D15/20B01D15/24B01D15/161B01J20/3433B01J20/3475B08B3/102F23G5/12F23G5/44F23G7/00B01D53/04B01D53/1437B01D53/18B01D2253/102B01D2253/116B01D2253/108B01D2258/02B01D2252/103
Inventor 李孟媛韩亚利李艳娜
Owner LUOYANG CENT HOSPITAL
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap